Total raised
$2.2M
Last: Seed 2025-11
Stage
Seed
Founded
2021
Headcount
5
HQ
Yokne'am Illit
Sector
Health Tech & Life Sciences
About
Levron is developing a novel autonomic integrated diagnostic and therapeutic minimally invasive device intended to be used with cardiac failure patients. The company's device integrates diagnosis and treatment, shifts fluids from the lung, and reduces cardiac workloads. The device provides adaptive treatment for NYHA stage 3 heart failure, eliminating lung congestion.
Funding history · 1 round · $2.2M total
2025-11
Seed
$2.2M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical EquipmentHealthcarePatients
Business model
B2C
Tags
therapeutic-devicesheart-failuremedical-devicescardiologyminimally-invasive